Michael Cannon
Michael Cannon is the director of health policy studies at the Cato Institute, a libertarian think tank based in Washington, D.C. He is known for his expertise in health care policy, particularly regarding the implications of government intervention in the pharmaceutical market. Cannon has been vocal about the potential negative consequences of price control measures, arguing that similar policies in other sectors have historically led to shortages and inefficiencies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 6.00 | 0.03% | +0% | 331,002,651 | 102,319 | $21,000,000 | 6,491$ |
| Totals | 1 | 331,002,651 | 102,319 | $21,000,000 | 6,491$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Michael Cannon, Director of Health Policy Studies at the Cato Institute, stated that it is reasonable for taxpayers to insist that everyone in the Medicaid program who can contribute do so.
6
United States:
Michael Cannon, director of health policy studies at the Washington-based libertarian-leaning Cato Institute think tank, commented on the implications of price controls.
5